[Neonatal group B beta-hemolytic (SbHBG) streptococcal infection].
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Group A beta-hemolytic streptococcal pharyngitis is an extremely common problem for the family physician. Clinical signs are not reliable in making the diagnosis. Infections with few or no symptoms are common. Throat culture is the best aid to diagnosis. One-quarter or more of family contacts harbor the organism. Good mamagement includes accurate bacteriologic diagnosis, adequate use of the appropriate penicillin preparation, repeat cultures, treatment of family members, if indicated, and recognition of the chronic carrier state.
OBJECTIVE: In light of a recent proposal to legislate group B streptococcal prevention strategies in New Jersey, this study examined obstetrician preferences and practices toward group B streptococcal prevention strategies in neonates. STUDY DESIGN: This was a mail survey of American College of Obstetricians and Gynecologists Fellows in New Jersey. Physician characteristics, existing guideline preferences, and reported actual group B streptococcal prevention practices were measured. RESULTS: Of the 695 potential respondents, 306 responses (44.7%) were received for analysis. Respondent stated preferences were for guidelines from the Centers for Disease and Prevention (74.5%), American College of Obstetricians and Gynecologists (12.7%), American Academy of Pediatrics (9.2%), and others (3.6%). The proportions of obstetricians who actually adhere to their stated preference were 57.5%, 64.1%, and 39.3% in Centers for Disease and Prevention, American College of Obstetricians and Gynecologists, and American Academy of Pediatrics group, respectively. Only 40.7% of the obstetricians cultured the anorectal/vaginal area for group B streptococcal carriers. An overwhelming 86.7% of obstetricians do not support legislation that regulates neonatal group B streptococcal preventing practices. CONCLUSIONS: Obstetrician preferences for use of existing group B streptococcal guidelines are often not reflected by their actual stated practices. However, obstetricians do not support legislative regulation of group B streptococcal prevention practices.
Immune status of apparently healthy Nepalese against hemolytic streptococci was studied by measuring antibodies to various streptococcal antigens such as streptolysin-O (SO), streptokinase (SK), deoxyribonuclease-B (DN-B) and streptococcal polysaccharide (SP). The normal range of anti-streptolysin-O (ASO), anti-streptokinase (ASK), anti-deoxyribonuclease-B (ADN-B) and anti-Streptococcus polysaccharide (ASP) was 60-480 (T.U.), 40-1024 (titer), 60-1280 (titer) and less than 2-128 (Unit), respectively. No difference was observed between the two sexes. ASO and ADN-B were measured by the neutralization method. Passive hemagglutination (PHA) was used to measure ASK and ASP. These values were 2-3 fold higher than those obtained on the Japanese subjects.
Explore the source record for details and available documents.
Near patient testing demonstrated an unusual infection pattern with a high incidence of Lancefield group D beta-haemolytic streptococci in patients with pharyngitis and tonsillitis in a London general practice. This raises questions regarding the epidemiology of this streptococcus strain, which is not usually associated with upper respiratory infections.
Explore the source record for details and available documents.